Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.945
+0.012 (1.24%)
Nov 7, 2024, 3:23 PM EST - Market open
RVPH Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -35.99 | -39.26 | -28.26 | -8.52 | -3.78 | -0.85 | |
| Depreciation & Amortization | - | - | - | - | 0 | 0 | |
| Stock-Based Compensation | 1.47 | 3.41 | 0.18 | 0.15 | - | - | |
| Other Operating Activities | -0.86 | 0.24 | 0.19 | -1.59 | 2.05 | -0.01 | |
| Change in Accounts Payable | 2.05 | 0.33 | 3.01 | -0.5 | 0.78 | 0.16 | |
| Change in Other Net Operating Assets | -1.91 | 6.96 | 5.92 | -0.2 | -3.1 | 0.48 | |
| Operating Cash Flow | -35.26 | -28.32 | -18.96 | -10.67 | -4.07 | -0.22 | |
| Short-Term Debt Issued | - | 0.67 | - | - | 3.11 | 0.1 | |
| Total Debt Issued | 0.42 | 0.67 | - | - | 3.11 | 0.1 | |
| Short-Term Debt Repaid | - | -0.67 | - | - | - | - | |
| Total Debt Repaid | -0.43 | -0.67 | - | - | - | - | |
| Net Debt Issued (Repaid) | -0.02 | - | - | - | 3.11 | 0.1 | |
| Issuance of Common Stock | 30.3 | 33.17 | 7.79 | 31.6 | 9.72 | - | |
| Financing Cash Flow | 30.28 | 33.17 | 7.79 | 31.6 | 12.83 | 0.1 | |
| Net Cash Flow | -4.97 | 4.85 | -11.17 | 20.93 | 8.76 | -0.12 | |
| Free Cash Flow | -35.26 | -28.32 | -18.96 | -10.67 | -4.07 | -0.22 | |
| Free Cash Flow Per Share | -1.27 | -1.19 | -0.97 | -0.72 | -1.33 | -0.08 | |
| Cash Interest Paid | 0.02 | 0.03 | - | - | 0.33 | - | |
| Cash Income Tax Paid | - | - | - | 0 | 0 | 0 | |
| Levered Free Cash Flow | -17.42 | -13.99 | -8.54 | -6.87 | -4.15 | 1.3 | |
| Unlevered Free Cash Flow | -17.42 | -13.99 | -8.54 | -6.87 | -3.24 | 1.59 | |
| Change in Net Working Capital | -4.39 | -7.28 | -8.93 | 0.7 | 1.72 | -1.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.